Glaxo Grows Off The Beaten Path
Drugmaker spends $667M on UCB operations in Asia, Africa, Latin America. The weakening world economy may have knocked many firms off course but Andrew Witty , the chief executive of GlaxoSmithKline, is sticking …
Popularity: 5% [?]
